Vernacare, the global developer of single‑use medical devices, has closed its purchase of Eakin Surgical, a UK‑based manufacturer of high‑quality surgical instruments. The deal, backed by H.I.G. Capital, sees Vernacare take over Eakin Surgical from its parent, Eakin Healthcare Group. The acquisition expands Vernacare’s footprint in the European market.

Eakin Surgical, headquartered in Cardiff, Wales, has built a reputation for precision instruments used in a variety of procedures. By joining Vernacare’s portfolio, the company gains access to a broader distribution network and R&D resources. Investors view the move as a strategic consolidation in the single‑use device segment amid growing demand for disposable solutions.

The transaction positions Vernacare to capture a larger share of the European market and reinforce its competitive edge in sterile consumables. With the acquisition, the company can leverage Eakin’s established manufacturing capabilities and client base. The deal signals continued investor confidence in the growth prospects of the single‑use medical device industry.

Analysts expect the combined entity to achieve cost synergies through streamlined supply chains and shared research initiatives. The expanded product line will also allow Vernacare to address unmet needs in minimally invasive procedures. For shareholders, the acquisition offers a pathway to enhanced earnings potential in a sector that has seen steady revenue growth during the pandemic.